Literature DB >> 31850822

Radiation induces an inflammatory response that results in STAT3-dependent changes in cellular plasticity and radioresistance of breast cancer stem-like cells.

Kimberly M Arnold1,2, Lynn M Opdenaker1,3, Nicole J Flynn1,3, Daniel Kwesi Appeah1,3, Jennifer Sims-Mourtada1,3.   

Abstract

Purpose: Pro-inflammatory cytokines within the tumor microenvironment, such as IL-6, contribute to the maintenance of stem cells and promote their survival following treatment. The IL-6/STAT3 pathway is a key regulator of genes involved in cancer progression. Activation of STAT3 promotes expansion of cancer stem cells in triple negative breast cancer. Radiation has also been shown to expand cancer stem cell populations and can induce stemness in nonstem cells. However, the role of IL-6/STAT3 in radiation-induced changes in cellular plasticity is unclear.Materials and methods: Expression and secretion of IL-6 from triple-negative breast cancer cell lines SUM159PT and MDA-MB-231 were determined after radiation treatment by real-time PCR and ELISA. Activation of STAT3 after radiation was determined by western blotting. Changes in cellular plasticity induced by radiation were determined by examining ALDEFLUOR activity, gene expression analysis of aldehyde dehydrogenase isoforms and mammosphere forming assays with and without the addition of STAT3 inhibitors. To determine the effect of radiation on nonstem cell populations, experiments were also carried out in ALDEFLUOR sorted cells.
Results: Radiation induced an inflammatory response in both cell lines that resulted in activation of STAT3. Additionally, radiation induced a stem-like state as evidenced by an increased activity and expression of the ALDH isoforms ALDH1A1 and ALDH1A3, and increased self-renewal capabilities. Radiation increased ALDH activity and self-renewal in non-stem cell (ALDH-) populations, suggesting radiation-induced cellular reprograming. However, inhibition of STAT3 blocked the radiation-induced stem-like state in both ALDEFLUOR positive and negative populations, and enhanced radiosensitivity.Conclusions: Radiation-induced changes in cellular plasticity are STAT3 dependent and may be a potential target to reduce radioresistance in TNBC and improve treatment outcome.

Entities:  

Keywords:  Breast; cancer; differentiation; inflammation

Mesh:

Substances:

Year:  2020        PMID: 31850822      PMCID: PMC7596771          DOI: 10.1080/09553002.2020.1705423

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  64 in total

1.  Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.

Authors:  Jochen Schust; Bianca Sperl; Angela Hollis; Thomas U Mayer; Thorsten Berg
Journal:  Chem Biol       Date:  2006-11

Review 2.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

3.  Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.

Authors:  Ina H Benoy; Roberto Salgado; Peter Van Dam; Katrien Geboers; Eric Van Marck; Simon Scharpé; Peter B Vermeulen; Luc Y Dirix
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

Review 4.  The role of intratumoral and systemic IL-6 in breast cancer.

Authors:  Christine Dethlefsen; Grith Højfeldt; Pernille Hojman
Journal:  Breast Cancer Res Treat       Date:  2013-03-27       Impact factor: 4.872

5.  Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.

Authors:  Seog-Young Kim; Jin Wook Kang; Xinxin Song; Bo Kyoung Kim; Young Dong Yoo; Yong Tae Kwon; Yong J Lee
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

6.  STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.

Authors:  Wei Wei; David J Tweardy; Mei Zhang; Xiaomei Zhang; John Landua; Ivana Petrovic; Wen Bu; Kevin Roarty; Susan G Hilsenbeck; Jeffrey M Rosen; Michael T Lewis
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

7.  A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo.

Authors:  Dang Vinh Do; Jun Ueda; Daniel M Messerschmidt; Chanchao Lorthongpanich; Yi Zhou; Bo Feng; Guoji Guo; Peiyu J Lin; Md Zakir Hossain; Wenjun Zhang; Akira Moh; Qiang Wu; Paul Robson; Huck Hui Ng; Lorenz Poellinger; Barbara B Knowles; Davor Solter; Xin-Yuan Fu
Journal:  Genes Dev       Date:  2013-06-15       Impact factor: 11.361

8.  A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations.

Authors:  Claudia Canino; YuYing Luo; Paola Marcato; Giovanni Blandino; Harvey I Pass; Mario Cioce
Journal:  Oncotarget       Date:  2015-05-20

9.  Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.

Authors:  Ying Zhong; Yan Lin; Songjie Shen; Yidong Zhou; Feng Mao; Jinghong Guan; Qiang Sun
Journal:  Cancer Cell Int       Date:  2013-06-15       Impact factor: 5.722

Review 10.  The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules.

Authors:  Kimberly M Arnold; Nicole J Flynn; Adam Raben; Lindsay Romak; Yan Yu; Adam P Dicker; Firas Mourtada; Jennifer Sims-Mourtada
Journal:  Cancer Growth Metastasis       Date:  2018-03-09
View more
  7 in total

1.  Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance.

Authors:  Heba Alkhatib; Ariel M Rubinstein; Amichay Meirovitz; Nataly Kravchenko-Balasha; Swetha Vasudevan; Efrat Flashner-Abramson; Shira Stefansky; Sangita Roy Chowdhury; Solomon Oguche; Tamar Peretz-Yablonsky; Avital Granit; Zvi Granot; Ittai Ben-Porath; Kim Sheva; Jon Feldman; Noa E Cohen
Journal:  Genome Med       Date:  2022-10-20       Impact factor: 15.266

2.  Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature.

Authors:  Mario Cioce; Andrea Sacconi; Harvey I Pass; Claudia Canino; Sabrina Strano; Giovanni Blandino; Vito Michele Fazio
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

3.  Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers.

Authors:  Nicole J Toney; Lynn M Opdenaker; Kader Cicek; Lisa Frerichs; Christopher Ryan Kennington; Samuel Oberly; Holly Archinal; Rajasekharan Somasundaram; Jennifer Sims-Mourtada
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

Review 4.  Radiation Resistance: A Matter of Transcription Factors.

Authors:  Chiara Galeaz; Cristina Totis; Alessandra Bisio
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

Review 5.  STAT3 Contributes to Radioresistance in Cancer.

Authors:  Xuehai Wang; Xin Zhang; Chen Qiu; Ning Yang
Journal:  Front Oncol       Date:  2020-07-07       Impact factor: 6.244

Review 6.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sima Orouei; Vahideh Zarrin; Ebrahim Rahmani Moghadam; Amirhossein Zabolian; Shima Mohammadi; Kiavash Hushmandi; Yashar Gharehaghajlou; Pooyan Makvandi; Masoud Najafi; Reza Mohammadinejad
Journal:  Biology (Basel)       Date:  2020-06-12

7.  Activated ERK Signaling Is One of the Major Hub Signals Related to the Acquisition of Radiotherapy-Resistant MDA-MB-231 Breast Cancer Cells.

Authors:  Anjugam Paramanantham; Eun Joo Jung; Se-Il Go; Bae Kwon Jeong; Jin-Myung Jung; Soon Chan Hong; Gon Sup Kim; Won Sup Lee
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.